ARCHIVES

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

Totality Of Evidence Causes Concern About New Findings.

December 7, 2007

Increased Breast Density Can Lead to Higher Risk

August 26, 2011

Sweden Approves Photofrin For Palliation Of Two Cancers.

July 28, 2000

ACS Lists Challenges For Global Tobacco Control

January 22, 2010

In Brief: USC Norris Opens Topping Tower March 21; Postal Service To Sell Breast Cancer Stamps

March 15, 1996

Fisher Unable To Answer Key Questions, Blames NCI, A Second Hearing On NSABP

June 24, 1994